trial · primary record
Sonesitatug Vedotin
Gastroesophageal Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2029-07-16 |
| Primary endpoint | Number of participants with adverse events (AEs) and serious adverse events (SAEs) |
| Registry ID | NCT07069712 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:16.383Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07069712
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.